Hospital of the University of Pennsylvania, Site #013 — Philadelphia, Pennsylvania

Hospital of the University of Pennsylvania, Site #013 is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Hospital of the University of Pennsylvania, Site #013 has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hospital of the University of Pennsylvania, Site #013?

Hospital of the University of Pennsylvania, Site #013 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hospital of the University of Pennsylvania, Site #013 conducted?

Hospital of the University of Pennsylvania, Site #013 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Is Hospital of the University of Pennsylvania, Site #013 accredited by Crixeo Health?

Hospital of the University of Pennsylvania, Site #013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hospital of the University of Pennsylvania, Site #013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.